Posts tagged ICICI-Direct
| Indo Count is poised for a healthy volume recovery in FY24E. Buy for target price of Rs 295 (25% upside) | |
| Company: | Indo Count Industries |
| Brokerage: | ICICI-Direct |
| Date of report: | August 21, 2023 |
| Type of Report: | Result Update |
| Recommendation: | Buy |
| Upside Potential: | 25% |
| Summary: | Government initiatives like signing of FTAs with multiple countries & stability in export incentive policy to provide robust opportunities for Indian exporters. ICIL through its sizeable capacity is well poised to capture the export opportunity in global home textile trade |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Indo Count |
| Sagar Cement Poised for a healthy uptick in operational performance. Buy for target price of Rs 305 (29% upside): ICICI Direct | |
| Company: | Sagar Cements |
| Brokerage: | ICICI-Direct |
| Date of report: | August 7, 2023 |
| Type of Report: | Result Update |
| Recommendation: | Buy |
| Upside Potential: | 29% |
| Summary: | Sagar Cement is trading at attractive valuations (US$ 50/t vs. replacement cost of US$ 110/t). We believe Sagar Cement is an attractive regional play in the southern cement markets and has demonstrated the ability to be one of the lowest cost producers. Hence, we ascribe BUY rating on the stock. |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Sagar Cements |
| PSP Projects is on a strong growth trajectory! Buy for target price of Rs 975 (25% upside): ICICI Direct | |
| Company: | PSP Projects Ltd |
| Brokerage: | ICICI-Direct |
| Date of report: | July 31, 2023 |
| Type of Report: | Result Update |
| Recommendation: | Buy |
| Upside Potential: | 25% |
| Summary: | PSP is well placed for healthy growth at decent margins to be driven by strong executable order book position. Healthy order inflows secured at FY23 and Q1FY24 coupled with robust bidding pipeline brightens company’s prospects. At the CMP, the company is trading at a valuation of ~12x FY25E P/E |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | PSP Projects Ltd |
| Ajanta Pharma is a focused player in branded generics. Buy for target price Rs 1950 (26% upside) | |
| Company: | Ajanta Pharma |
| Brokerage: | ICICI-Direct |
| Date of report: | August 28, 2023 |
| Type of Report: | Result Update |
| Recommendation: | Buy |
| Upside Potential: | 26% |
| Summary: | Ajanta Pharma is a focused player in branded generics, which constitutes ~72% of overall sales, spread across geographies including India. |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Ajanta Pharma |
| HDFC Bank is a conviction buy for target price of Rs 2050 (26% upside): ICICI Direct | |
| Company: | HDFC Bank |
| Brokerage: | ICICI-Direct |
| Date of report: | August 4, 2023 |
| Type of Report: | Result Update |
| Recommendation: | Buy |
| Upside Potential: | 26% |
| Summary: | Valuing the merged entity on SOTP basis assigning 2.5x FY25E ABV for lending business (merged basis) and ₹ 144 for subsidiaries arriving at a target of ₹ 2050 per share. Maintain BUY rating on the stock |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | HDFC Bank |
| Delhivery Ltd is a BUY (HIGH CONVICTION IDEA): ICICI Direct | |
| Company: | Delhivery Ltd |
| Brokerage: | ICICI-Direct |
| Date of report: | July 7, 2023 |
| Type of Report: | Initiating Coverage |
| Recommendation: | Buy |
| Upside Potential: | 28% |
| Summary: | Delhivery has shown strong growth and built a recognisable brand in a segment marred by intense competition and low barriers to entry. |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Delhivery Ltd |
| Garden Reach Shipbuilders & Engineers (Stock In Ramesh Damani Portfolio) is a buy for target price of Rs 630 (36% gain): ICICI Direct | |
| Company: | Garden Reach Shipbuilders & Engineers, GRSE |
| Brokerage: | ICICI-Direct |
| Date of report: | January 11, 2023 |
| Type of Report: | Initiating Coverage |
| Recommendation: | Buy |
| Upside Potential: | 36% |
| Summary: | Garden Reach Shipbuilders & Engineers (GRSE), one of India’s leading defence public sector undertaking shipyards, primarily caters to the shipbuilding requirements of the Indian Navy and the Indian Coast Guard |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Garden Reach Shipbuilders & Engineers |
| CanFin Homes is in sweet spot. Buy for target price of Rs 625: ICICI Direct | |
| Company: | Can Fin Homes |
| Brokerage: | ICICI-Direct |
| Date of report: | January 2, 2023 |
| Type of Report: | Initiating Coverage |
| Recommendation: | Buy |
| Upside Potential: | 17% |
| Summary: | Consistent business growth with focus on efficient operations coupled with relatively lower cost and strong underwriting to benefit earnings and return ratios |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Can Fin Homes |
| Risk reward still favours PSU bank valuations. Top 3 Stock Picks By ICICI Direct | |
| Company: | Model Portfolio, PSU Banks |
| Brokerage: | ICICI-Direct |
| Date of report: | December 22, 2022 |
| Type of Report: | Sector Report |
| Recommendation: | Buy |
| Upside Potential: | 27% |
| Summary: | A stellar run up by PSU banks had all eyes glued towards them. We tried to analyse the factors leading to the rally and what is in store ahead |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Model Portfolio, PSU, PSU Banks |
| Top 9 Techno-Funda Stock Picks for CY23 by ICICI Direct | |
| Company: | Model Portfolio |
| Brokerage: | ICICI-Direct |
| Date of report: | December 20, 2022 |
| Type of Report: | Model Portfolio |
| Recommendation: | Buy |
| Upside Potential: | 100% |
| Summary: | History does not repeat but it rhymes: Indian equities are likely to display the same rhythm that the US and Nikkei did in 1990-2000 and 1980-1990, respectively, i.e. delivering a decadal move of 5x on headline indices. Our prognosis of various Technical studies leads us to the conclusion that the Nifty is poised to reach towards 50000 by CY30. More so, the performance of 2021 and 2022 further adds strength to our argument given the Nifty is mimicking our forecast trajectory. What is more exciting is that we are entering 2023, which, as per decadal studies, has turned out to be a strong year |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Model Portfolio |